Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients

From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supp...

Full description

Saved in:
Bibliographic Details
Published in:Journal of translational medicine 2010-11, Vol.8 (S1), p.I3-I3, Article I3
Main Authors: Aarntzen, EHJG, Lesterhuis, W J, Van Rossum, M, Adema, G J, Figdor, C F, Punt, CJA, De Vries, IJM
Format: Article
Language:English
Subjects:
Immunology
Invited Lecture Presentation
Life sciences
Medical research
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:From: 5th European Workshop on Immune-Mediated Inflammatory Diseases Sitges-Barcelona, Spain 1-3 December 2010 Author details 1-Dept. of Tumor Immunology and Medical Oncology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The NetherlandsEMPTY Supplemental Information:
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-8-S1-I3